The protective effects of ONO-AE3-208 on peritoneal fibrosis were further demonstrated by its ability to inhibit FN, collagen I, and vimentin at both the mRNA and protein levels (Figures 6D–L). The gene discussed is VIM; the disease is Peritoneal Fibrosis.